Figure 1. Trends of global cardio-oncology research. Results from bibliometric analysis from 1864 to 2020 illustrate number of publications (a) and number of citations of articles (b) in cardio-oncology.
| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website https://www.cardiologyres.org |
Original Article
Volume 12, Number 5, October 2021, pages 309-317
An Analysis of Global Research Trends and Top-Cited Research Articles in Cardio-Oncology
Figure
Tables
| Citations | Year | Journal | Authors | Corresponding author (Country) | Title | Document type | Corresponding author field | |
|---|---|---|---|---|---|---|---|---|
| aData as of final search date March 31, 2021. bPP or Guide: position paper or guideline. | ||||||||
| 1 | 986 | 2016 | European Heart Journal | Zamorano JL et al | Zamorano JL (Spain) | 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines | PP or Guideb | Cardiology |
| 2 | 499 | 2010 | Journal of the National Cancer Institute | Albini A et al | Albini A (Italy) | Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention | Review | Molecular oncology |
| 3 | 463 | 2012 | Annals of Oncology | Curigliano G et al | Curigliano G (Italy) | Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines | PP or Guide | Oncology |
| 4 | 321 | 2018 | Journal of the American College of Cardiology | Mahmood SS et al | Neilan TG (USA) | Myocarditis in Patients Treated with Immune Checkpoint Inhibitors | Original article | Cardiology |
| 5 | 288 | 2011 | European Journal of Heart Failure | Eschenhagen T et al | Eschenhagen T (Germany) | Cardiovascular side effects of cancer therapies: A position statement from the Heart Failure Association of the European Society of Cardiology | PP or Guide | Cardiology |
| 6 | 270 | 2014 | Journal of the American College of Cardiology | Ky B et al | Ky B (USA) | Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab | Original article | Cardiology |
| 7 | 256 | 2013 | European Heart Journal | Suter TM et al | Suter TM (Switzerland) | Cancer drugs and the heart: Importance and management | Review | Cardiology |
| 8 | 218 | 2017 | Canadian Journal of Cardiology | Ezekowitz JA et al | Ezekowitz JA (Canada) | 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure | PP or Guide | Cardiology |
| 9 | 203 | 2012 | Journal of the American College of Cardiology | Chen J et al | Chen J (USA) | Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer | Original article | Cardiology |
| 10 | 199 | 2013 | JACC: Cardiovascular Imaging | Drafts BC et al | Hundley WG (USA) | Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease | Original article | Cardiology |
| 11 | 184 | 2016 | CA: A Cancer Journal for Clinicians | Curigliano G et al | Curigliano G (Italy) | Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management | Review | Oncology |
| 12 | 172 | 2014 | Mayo Clinic Proceedings | Herrmann J et al | Herrmann J (USA) | Evaluation and management of patients with heart disease and cancer: Cardio-oncology | Review | Cardiology |
| 13 | 164 | 2017 | Journal of the American College of Cardiology | Collier P et al | Collier P (USA) | A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography | Review | Cardiology |
| 14 | 146 | 2014 | Journal of the American Heart Association | Hahn VS et al | Lenihan DJ (USA) | Cancer therapy-induced cardiotoxicity: Basic mechanisms and potential cardioprotective therapies | Review | Cardiology |
| 15 | 143 | 2017 | Journal of Clinical Oncology | Pituskin E et al | Paterson DI (Canada) | Multidisciplinary approach to novel therapies in cardio-oncology research (MANTICORE 101-Breast): A randomized trial for the prevention of trastuzumab-associated cardiotoxicity | Original article | Cardiology |
| 16 | 140 | 2014 | Journal of the American College of Cardiology | Farmakis D et al | Filippatos G (Greece) | Insights Into Onco-Cardiology Atrial Fibrillation in Cancer | Review | Cardiology |
| 17 | 126 | 2016 | Circulation Research | Lenneman CG et al | Lenneman CG (USA) | Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment | Review | Cardiology |
| 18 | 118 | 2015 | Plos One | Focaccetti C et al | Albini A (Italy) | Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes | Original article | Molecular oncology |
| 19 | 111 | 2015 | Journal of the American College of Cardiology | Barac A et al | Barac A (USA) | Cardiovascular health of patients with cancer and cancer survivors: A roadmap to the next level | Review | Cardiology |
| 20 | 110 | 2012 | Experimental and Molecular Pathology | Weerasinghe, P et al | Weerasinghe P (USA) | Oncosis: An important non-apoptotic mode of cell death | Review | Pathology |
| 21 | 108 | 2013 | Drug Safety | Shah RR et al | Shah RR (UK) | Cardiovascular safety of tyrosine kinase inhibitors: With a special focus on cardiac repolarisation (QT Interval) | Review | Cardiology |
| 22 | 104 | 2013 | Circulation Research | Ky B et al | Moslehi J (USA) | Emerging paradigms in cardiomyopathies associated with cancer therapies | Review | Cardiology |
| 23 | 92 | 2017 | Oncotarget | Koleini N et al | Kardami E (Canada) | Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity | Review | Molecular biology |
| 24 | 91 | 2016 | Canadian Journal of Cardiology | Virani SA et al | Virani SA (Canada) | Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy | PP or Guide | Cardiology |
| 25 | 89 | 2015 | Journal of the American College of Cardiology | Li W et al | Moslehi J (USA) | Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors | Review | Cardiology |
| 26 | 82 | 2014 | Journal of Pineal Research | Govender J et al | Engelbrecth, A (South Africa) | Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: A review of the protective role of melatonin | Review | Physiology |
| 27 | 79 | 2019 | Cardiovascular Research | Hu JR et al | Mosheli J (USA) | Cardiovascular toxicities associated with immune checkpoint inhibitors | Review | Cardiology |
| 28 | 73 | 2017 | Lancet Oncology | Levis BE et al | Shapiro CL (USA) | Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? | Review | Oncology |
| 29 | 73 | 2020 | Annals of Oncology | Curigliano G et al | ESMO Guidelines Committee | Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations | PP or Guide | Oncology |
| 30 | 69 | 2019 | European Heart Journal | Lancellotti P et al | Lancelloti P (Belgium) | Cardio-oncology services: Rationale, organization, and implementatio: A report from the ESC Cardio-Oncology council | Review | Cardiology |
| 31 | 69 | 2018 | European Journal of Cancer | Cardinale D et al | Latini R (Italy) | Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial | Original article | Cardiology |
| 32 | 68 | 2017 | Journal for Immunotherapy of Cancer | Norwood TG et al | Conry RM (USA) | Smoldering myocarditis following immune checkpoint blockade | Case Report | Oncology |
| 33 | 68 | 2016 | Catheterization and Cardiovascular Interventions | Iliescu CA et al | Marmagkiolis K (USA) | SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologa intervencionista) | PP or Guide | Cardiology |
| 34 | 68 | 2015 | Circulation | Bellinger AM et al | Moslehi J (USA) | Cardio-oncology: How new targeted cancer therapies and precision medicine can inform cardiovascular discovery | Review | Cardiology |
| 35 | 67 | 2016 | Mayo Clinic Proceedings | Al-Kindi SG et al | Oliveira GH (USA) | Prevalence of Preexisting Cardiovascular Disease in Patients with Different Types of Cancer the Unmet Need for Onco-Cardiology | Original article | Cardiology |
| 36 | 66 | 2010 | Journal of Pharmacology and Experimental Therapeutics | Minotti G et al | Minotti G (Italy) | Pharmacological foundations of cardio-oncology | Review | Pharmacology |
| 37 | 65 | 2013 | Journal of Nuclear Cardiology | Schwartz RG et al | Storozynsky E (USA) | Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively | Review | Cardiology |
| 38 | 64 | 2018 | Pharmacological Research | Cappetta D et al | De Angelis A (Italy) | Doxorubicin targets multiple players: A new view of an old problem | Review | Cardiology |
| 39 | 63 | 2019 | Circulation | Bonaca MP et al | Bonaca MP (USA) Moslehi J (USA) | Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology | Review | Cardiology |
| 40 | 61 | 2019 | European Heart Journal | Sturgeon KM et al | Zaorsky NG (USA) | A population-based study of cardiovascular disease mortality risk in US cancer patients | Original article | Radiation oncology |
| 41 | 60 | 2017 | Revista Espanola de Cardiologia | Lopez-Fernandez T et al | Lopez-Fernandez T (Spain) | Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations (Cardio-Onco-Hematologia en la practica clinica. Documento de consenso y recomendaciones) | PP or Guide | Cardiology |
| 42 | 59 | 2010 | Clinical Cardiology | Hong RA et al | Limura T (USA) | Cardio-oncology/onco-cardiology | Review | Internal medicine |
| 43 | 59 | 2016 | World Journal of Cardiology | Cuomo JR et al | Weintraub NL (USA) | Novel concepts in radiation-induced cardiovascular disease | Review | Cardiology |
| 44 | 58 | 2018 | Circulation | Scott, JM et al | Scott JM (USA) | Exercise Therapy and Cardiovascular Toxicity in Cancer | Review | Exercise oncology |
| 45 | 58 | 2014 | International Journal of Cardiology | Patane S | Patane S (Italy) | Cardiotoxicity: Cisplatin and long-term cancer survivors | Letter to Editor | Cardiology |
| 46 | 58 | 2018 | Basic Research in Cardiology | Davidson SM et al | Yellon DM (UK) | The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection - evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology | Meeting Report | Molecular and cellular cardiology |
| 47 | 53 | 2016 | Canadian Journal of Cardiology | Johnson CB et al | Johnson CB (Canada) | Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients | Review | Cardiology |
| 48 | 52 | 2019 | Circulation | Gilchrist SC et al | American Heart Association (USA) | Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement from the American Heart Association | PP or Guide | Cardiology |
| 49 | 50 | 2017 | Journal of the American Heart Association | Porta-Sanchez A et al | Thavendiranathan P (Canada) | Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: A systematic review | Systematic review | Cardiology |
| 50 | 49 | 2013 | Journal of the American College of Cardiology | Lal H et al | Force T (USA) | Cancer Genetics and the Cardiotoxicity of the Therapeutics | Review | Cardiology |
| Journal title | Number of published articles |
|---|---|
| aData as of final search date March 31, 2021. | |
| JACC: Cardiooncology | 51 |
| Circulation | 47 |
| International Journal of Cardiology | 40 |
| Journal of the American College of Cardiology | 40 |
| European Journal of Heart Failure | 36 |
| Current Treatment Options in Cardiovascular Medicine | 30 |
| European Heart Journal | 23 |
| Cardiooncology | 22 |
| Journal of the American Heart Association | 19 |
| Current Cardiology Reports | 18 |